The forecast for new extrapulmonary tuberculosis (EPTB) cases in the US suggests a gradual decline from 1.5 thousand cases in 2024 to 1.31 thousand cases by 2028. This indicates a shrinking annual trend of 3.33% from 2025 to 2026, 3.57% from 2026 to 2027, and 2.96% from 2027 to 2028. From 2023 figures, this reflects a compound annual growth rate (CAGR) of approximately -2.99% over five years, showing a consistent annual reduction.
Future trends to monitor include:
- Development and distribution of new vaccines or treatments.
- Impact of healthcare policy changes on disease tracking and management.
- Socioeconomic factors affecting tuberculosis spread and control efforts.
